# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-122544
Filing Date
2019-04-26
Accepted
2019-04-26 16:49:03
Documents
3
Effectiveness Date
2019-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d737296ddefa14a.htm | DEFA14A | 18513
2 | GRAPHIC | g737296img1.jpg | GRAPHIC | 340119
3 | GRAPHIC | g737296img2.jpg | GRAPHIC | 277741
| Complete submission text file | 0001193125-19-122544.txt |  | 870919

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 19772384
SIC: 2834 Pharmaceutical Preparations